LER & CER: letter to Editor Rheumatology
Comment on: Evaluation of the nocebo effect after switching from etanercept or adalimumab originator to a biosimilar: a retrospective study of patients with inflammatory rheumatism
V. Torrente-Segarra1, C. Rojas2, M. Bonet3
- Department of Rheumatology, Hospital Comarcal Alt Penedès-Garraf (CSAPG), Vilafranca del Penedès, Spain. vtorrente@csapg.cat
- Department of Rheumatology, Hospital Comarcal Alt Penedès-Garraf (CSAPG), Vilafranca del Penedès, Spain.
- Department of Rheumatology, Hospital Comarcal Alt Penedès-Garraf (CSAPG), Vilafranca del Penedès, Spain.
CER18934
LER & CER: letter to Editor Rheumatology
Free to view
(click on article PDF icon to read the article)
PMID: 40920065 [PubMed]
Received: 20/05/2025
Accepted : 14/07/2025
In Press: 05/09/2025
